Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Preferred Shares (2022 - 2026)

HeartSciences filings provide 5 years of Preferred Shares readings, the most recent being $537.0 for Q1 2026.

  • On a quarterly basis, Preferred Shares rose 41.32% to $537.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $537.0, a 41.32% increase, with the full-year FY2025 number at $380.0, changed 0.0% from a year prior.
  • Preferred Shares hit $537.0 in Q1 2026 for HeartSciences, down from $580.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $580.0 in Q4 2025 to a low of $380.0 in Q3 2023.
  • Median Preferred Shares over the past 5 years was $380.5 (2023), compared with a mean of $416.88.
  • Biggest five-year swings in Preferred Shares: decreased 21.12% in 2023 and later skyrocketed 52.63% in 2025.
  • HeartSciences' Preferred Shares stood at $403.0 in 2022, then fell by 5.71% to $380.0 in 2023, then changed by 0.0% to $380.0 in 2024, then skyrocketed by 52.63% to $580.0 in 2025, then dropped by 7.41% to $537.0 in 2026.
  • The last three reported values for Preferred Shares were $537.0 (Q1 2026), $580.0 (Q4 2025), and $430.0 (Q3 2025) per Business Quant data.